Precision Business Insights
Portfolio

 

Hepatitis Virus Testing Market

: Global Market Estimation, Dynamics, Trends, Competitor Analysis 2014-2018 and Forecast 2019-2025

Global Hepatitis Virus Testing Market: By Technique (Probe Amplification, Target Amplification, Signal Amplification), By Application (Cancer, Infectious Diseases, Genetics, Personalized Medicine), By End User (Hospitals, Diagnostic Centers, Research organizations, Others) and Geography

 

Global hepatitis virus testing market was valued at US $ XX Mn and expected to grow at XX% Compound Annual Growth Rate (CAGR) over 2018 to 2024.

 

Market Outline: Hepatitis Virus Testing Market

Liver is an essential organ of the body in which performs critical functions that affect the metabolism in the body. Hepatitis refers to the inflammatory condition of the liver and caused by the viral infection or medications. Hepatitis is considered as the sexually transmitted disease. Hepatitis can be classified into hepatitis A, hepatitis, B, hepatitis C, based on the virus. These are confirmed through the laboratory tastings. Various tests are available in the market based on the type of hepatitis.

 

Market Dynamics: Hepatitis Virus Testing Market

Global hepatitis testing market primarily driven by increase in prevalence viral hepatitis globally. According to World Health Organization, 130 – 150 million people are suffering with th chronic hepatitis c globally and there were many undiagnosed.  In addition, increase in healthcare expenditure, lifestyle changes and various initiatives by organizations such as World Health Organization in creating awareness of disease among population projected to boost the market growth. Furthermore, advancements in the diagnostics which quickly produce the test results coupled with increase in investments expected to bolster the market growth over the forecast period. However, lack of awareness among the people in under developing countries and high cost for developing techniques may hamper the market growth over the forecast period.

 

Market Scope: Hepatitis Virus Testing Market

Hepatitis virus market is segmented based on the technique, application and end user

Based on virus, the market is segmented into the following:

  • Hepatitis A Virus
  • Hepatitis B Virus
  • Hepatitis C Virus

Based on techniques, the market is segmented into the following:

  • Polymeric Chain Reaction Tests
  • Immunoassays
  • Others

Based on end user, the market is segmented into the following:

  • Hospitals
  • Diagnostic Centers
  • Others

Geography

North America

  • US
  • Canada

Europe

  • Germany
  • France
  • UK
  • Italy
  • Spain
  • Russia
  • Poland
  • Rest of Europe

Asia-Pacific

  • Japan
  • China
  • India
  • Australia & New Zealand
  • ASEAN (Includes Indonesia, Thailand, Vietnam, Philippines, Malaysia, and Others)
  • South Korea
  • Rest of Asia-Pacific

Latin America

  • Brazil
  • Mexico
  • Argentina
  • Venezuela
  • Rest of Latin America

Middle East and Africa (MEA)

  • Gulf Cooperation Council (GCC) Countries
  • Israel
  • South Africa
  • Rest of MEA

 

Regional Analysis:  Hepatitis Virus Testing Market

Geographically, global hepatitis virus testing market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. Due to availability of advanced diagnostic infrastructure and awareness on hepatitis disease among the U.S. population North America Projected to grow at significant growth rates in coming years. Furthermore, government initiatives, favorable reimbursement policies expected to boost the regional market. For instance, Public Health Agency of Canada organized the world hepatitis day to increase the awareness among the populace. Asia Pacific hepatitis virus testing market proejected to grow at notable rates owing to the significant increase in healthcare infrastructure and raise in awareness coupled with government support.

 

Competition Assessment: Hepatitis Virus Testing Market

Some of the players in the global hepatitis virus testing market include:

  • Hoffmann-La Roche AG (Switzerland)
  • Beckman Coulter, Inc. (U.S.)
  • Becton, Dickinson and Company (U.S.)
  • Abbott Laboratories, Inc. (U.S.)
  • bioMérieux (France)
  • Siemens Healthineers (Germany)
  • Novartis AG (Switzerland)
  • MedMira, Inc.

Notable Market Developments: Hepatitis Virus Testing Market

  • In March 2017, U.S. Food and Drug Administration has approved Siemens Healthineer’s Versant HCV Genotype 2.0 line probe (LiPA) for HCV testing
    
$ 3,000.00$ 8,900.00
Clear selection

Select License Type

Databank $ 3,000.00
spinner
Single User $ 4,400.00
spinner
Multiple User $ 6,600.00
spinner
Corporate User $ 8,900.00
spinner
buy now spinner
FacebookTwitterLinkedinEmail

Our Clients

Testimonials